Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04946370 |
Title | Maximizing Responses to Anti-PD1 Immunotherapy With PSMA-targeted Alpha Therapy in mCRPC |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Weill Medical College of Cornell University |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana-Farber Cancer Institute | Not yet recruiting | Boston | Massachusetts | 02215 | United States | Details |
New York Presbyterian/Brooklyn Methodist Hospital | Not yet recruiting | Brooklyn | New York | 11215 | United States | Details |
New York Presbyterian/Weill Cornell Medical Center | Recruiting | New York | New York | 10021 | United States | Details |
Columbia University Irving Cancer Center | Not yet recruiting | New York | New York | 10032 | United States | Details |